Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
55.32
-1.32 (-2.32%)
Jul 23, 2026, 11:30 AM EDT - Market open
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $1.35 billion as of July 23, 2026. Its market cap has increased by 961.04% in one year.
Market Cap
1.35B
Enterprise Value
1.29B
1-Year Change
961.04%
Ranking
Category
Stock Price
$55.32
ChartMarket Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has increased from $181.43M to $1.35B, an increase of 644.99%. That is a compound annual growth rate of 38.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 1.35B | 177.97% |
| Dec 31, 2025 | 486.26M | 234.91% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.23B |
| MannKind | 1.23B |
| Alpha Tau Medical | 1.21B |
| Corvus Pharmaceuticals | 1.19B |
| Jade Biosciences | 1.17B |
| MeiraGTx Holdings | 1.13B |
| Capricor Therapeutics | 1.13B |
| Wave Life Sciences | 1.10B |